Related references
Note: Only part of the references are listed.Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis
Benedikt Kortuem et al.
ONCOGENE (2022)
The role of S100A4 for bone metastasis in prostate cancer cells
Bongjun Kim et al.
BMC CANCER (2021)
Screening and prevention of colorectal cancer
Priyanka Kanth et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1
Dennis Kobelt et al.
FRONTIERS IN IMMUNOLOGY (2020)
Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways
Faiza Naz et al.
MOLECULES (2020)
Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years
Jianbo Zhou et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Clinical relevance of circulating MACC1 and S100A4 transcripts for ovarian cancer
Theresa Link et al.
MOLECULAR ONCOLOGY (2019)
Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer
Yanhong Pan et al.
FRONTIERS IN PHARMACOLOGY (2019)
Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells
Xiumei Zhang et al.
PLOS ONE (2019)
Overview of Cantharidin and its Analogues
Guofang Wang et al.
CURRENT MEDICINAL CHEMISTRY (2018)
MACC1-the first decade of a key metastasis molecule from gene discovery to clinical translation
Harikrishnan Radhakrishnan et al.
CANCER AND METASTASIS REVIEWS (2018)
The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer
Meng-Dan Xu et al.
ONCOGENESIS (2018)
Cantharidin suppressed breast cancer MDA-MB-231 cell growth and migration by inhibiting MAPK signaling pathway
X. -D. Gu et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2017)
Norcantharidin induces apoptosis in human prostate cancer cells through both intrinsic and extrinsic pathways
Pei-Yu Yang et al.
PHARMACOLOGICAL REPORTS (2016)
S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction
Mathias Dahlmann et al.
CANCERS (2016)
Cantharidin and norcantharidin impair sternness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib
Wen-Jie Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis
Mathias Dahlmann et al.
ONCOTARGET (2014)
Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
Chen-Hsi Hsieh et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
Ulrike Sack et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
MACC1-more than metastasis? Facts and predictions about a novel gene
Ulrike Stein et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
The Effects of Cantharidin and Cantharidin Derivates on Tumour Cells
Dongwu Liu et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
Colon cancer metastasis: MACC1 and Met as metastatic pacemakers
Franziska Arlt et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis
Ulrike Stein et al.
NATURE MEDICINE (2009)
Share Paper
